The potential for microRNA therapeutics and clinical research

J Hanna, GS Hossain, J Kocerha - Frontiers in genetics, 2019 - frontiersin.org
As FDA-approved small RNA drugs start to enter clinical medicine, ongoing studies for the
microRNA (miRNA) class of small RNAs expand its preclinical and clinical research …

Circulating microRNAs as potential biomarkers in pancreatic cancer—advances and challenges

AA Seyhan - International journal of molecular sciences, 2023 - mdpi.com
There is an urgent unmet need for robust and reliable biomarkers for early diagnosis,
prognosis, and prediction of response to specific treatments of many aggressive and deadly …

Trials and tribulations of MicroRNA therapeutics

AA Seyhan - International Journal of Molecular Sciences, 2024 - mdpi.com
The discovery of the link between microRNAs (miRNAs) and a myriad of human diseases,
particularly various cancer types, has generated significant interest in exploring their …

[HTML][HTML] MiR-21-5p and miR-126a-3p levels in plasma and circulating angiogenic cells: relationship with type 2 diabetes complications

F Olivieri, L Spazzafumo, M Bonafè, R Recchioni… - Oncotarget, 2015 - ncbi.nlm.nih.gov
Innovative biomarkers are required to manage type 2 diabetic patients (T2DM). We focused
our study on miR-126-3p and miR-21-5p levels, as biomarkers of endothelial function and …

An agomir of miR-144-3p accelerates plaque formation through impairing reverse cholesterol transport and promoting pro-inflammatory cytokine production

YW Hu, YR Hu, JY Zhao, SF Li, X Ma, SG Wu, JB Lu… - PloS one, 2014 - journals.plos.org
Aims ATP-binding cassette transporter A1 (ABCA1) mediates the efflux of cholesterol and
phospholipids to lipid-poor apolipoproteins, which then form nascent HDL, a key step in the …

Extracellular microRNAs induce potent innate immune responses via TLR7/MyD88-dependent mechanisms

Y Feng, L Zou, D Yan, H Chen, G Xu… - The Journal of …, 2017 - journals.aai.org
Tissue ischemia, such as transient myocardial ischemia, leads to release of cellular RNA
including microRNA (miRNA) into the circulation and extracellular (ex-) space, but the …

Systemic approach to identify serum microRNAs as potential biomarkers for acute myocardial infarction

A Hsu, SJ Chen, YS Chang, HC Chen… - BioMed research …, 2014 - Wiley Online Library
Background. Recent studies have revealed the role of microRNAs (miRNAs) in a variety of
biological and pathological processes, including acute myocardial infarction (AMI). We …

Non‐coding RNAs in aortic dissection: from biomarkers to therapeutic targets

M Cheng, Y Yang, H Xin, M Li, T Zong… - Journal of cellular …, 2020 - Wiley Online Library
Aortic dissection (AD) is the rupture of the aortic intima, causing the blood in the cavity to
enter the middle of the arterial wall. Without urgent and proper treatment, the mortality rate …

[HTML][HTML] Ischemic postconditioning-regulated miR-499 protects the rat heart against ischemia/reperfusion injury by inhibiting apoptosis through PDCD4

J Zhu, K Yao, Q Wang, J Guo, H Shi, L Ma… - Cellular Physiology and …, 2016 - karger.com
Background: Here, we determined miR-499 involvement in the protective effect of ischemic
postconditioning (IPC) against myocardial ischemia/reperfusion (I/R) injury and identified the …

The efficiency of blackberry loaded AgNPs, AuNPs and Ag@ AuNPs mediated pectin in the treatment of cisplatin-induced cardiotoxicity in experimental rats

J Hussein, ME El-Naggar, MMG Fouda… - International Journal of …, 2020 - Elsevier
Cisplatin (cis-Diaminedichloroplatinum) is one of the most effective chemotherapeutic
because of its anti-neoplastic properties against various types of tumor. However, it has a …